AXS Cannabis ETF

THCX

Capitalización de mercado USD 12.9 M

During the week, several new ETFs debuted on the U.S. market, but the ETF industry was fairly quiet overall. Just five funds launched from issuers including KraneShares, Morgan Stanley subsidiary Eaton Vance, Direxion, and American Beacon.

One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA).

Cannabis investors are tired of waiting and losing money, but there are still reasons to be optimistic in the long term.